Nine new stores were opened in Q4, meeting the 2024 target of 22 organic openings for the year. Walsh confirmed plans to open 25 to 30 new stores in 2025, emphasizing the U.S. as a key growth market ...

Last year, the stock declined 62.6%, significantly underperforming the S&P 500 Index’s ($SPX) gain of 25%. Moderna reported ...

Viking Global Investors' billionaire chief kicked Tesla to the curb in the December-ended quarter in favor of an ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.

Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...